about
Role of microRNAs in Alcohol-Induced Multi-Organ InjuryHedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsOverexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition.A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cellsmiR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinomaA role for miR-296 in the regulation of lipoapoptosis by targeting PUMAXIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells.Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C/EBP homologous proteinMechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosisSaturated fatty acids induce post-transcriptional regulation of HAMP mRNA via AU-rich element-binding protein, human antigen R (HuR).Mitochondrial DNA mutations, apoptosis, and the misfolded protein response.Overview of microRNA biology.Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death.TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouseDelivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness.MicroRNAs: key modulators of posttranscriptional gene expression.Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.Saturated free fatty acids induce cholangiocyte lipoapoptosis.Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosisCHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosisPalmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosisSerine 64 phosphorylation enhances the antiapoptotic function of Mcl-1.Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family.Genomic structure of murine mitochondrial DNA polymerase-gamma.Anatomical distribution of glycoprotein 93 (gp93) on nerve fibers during rat brain development.Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.Evidence for Pipecolate Oxidase in Mediating Protection Against Hydrogen Peroxide Stress.Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy.Construction of transgenic mice with tissue-specific acceleration of mitochondrial DNA mutagenesisOxidative stress is not an obligate mediator of disease provoked by mitochondrial DNA mutationsProteasome inhibition attenuates hepatic injury in the bile duct-ligated mouseMitochondrial DNA mutations cause resistance to opening of the permeability transition pore
P50
Q26776506-52CA60FC-10B8-420F-92E6-582990359857Q33869744-B70DCFEF-3DE0-44A7-BEDA-2AA1AF551C10Q33889618-53FBA57B-1A92-4E91-B5E9-C327BC306AB8Q34012890-F7FE08DD-EFD8-4D17-B672-2A2885B8E0AFQ34070935-837119C2-F691-4CFC-A470-37E723AADD31Q34212347-565507A3-3645-452B-B8A1-18AD1F6CDA2FQ34219872-555DE08A-E31D-4EDC-A306-45DB4657C014Q35107291-05197E42-CF93-44EC-8EA3-AFB2B8601024Q35113164-EB36EC43-C69A-45CD-95A3-5556F7742019Q35330939-B2544B88-CC57-4F7E-9622-ADBF9AE48AB6Q35939383-A9130306-EF21-4405-9870-EC2F1418432FQ36115798-F09AD99D-170A-4D1E-B3F1-8890EAD53423Q36324854-37D9619F-0AA9-4116-9EE3-876C8AF3F19AQ36702371-133DAF86-9ED9-4584-9F74-DA1070BE2314Q36892623-023C7941-D8EE-413F-BDD1-308039BF23E2Q36943407-1FA878E8-1FB1-4E13-B602-A530D3F06FE6Q37045471-000CC7F1-F530-40B3-841E-FFDE15F4CF2CQ37339409-D5E68100-3242-4380-9D57-19BDD53E3137Q38779932-CEC03C8A-E515-4B69-B711-3A0FA9A0112AQ39002205-E3CDF20F-798C-405A-B6F3-4087020DB15CQ39450591-FFD437DD-3A8B-47EC-A0A3-D041886F1733Q39690748-4217C8D9-E3C7-4D4D-9D7E-729CD2279770Q39709114-2FAA73FB-A0DE-4EB1-B530-3DF699D195BBQ39731721-361171AE-FE58-44F3-9C4D-9F937C4D4C69Q39875342-ABBDA202-AF76-40B7-986C-87A57FA64C18Q39947763-7D67A0B8-08D8-4526-8D8A-C66017E22966Q40140473-44D0EAFE-1E3B-45F9-B241-1C784D2812F8Q41095794-7AF07740-B485-4B1C-B15D-2FBA9994904CQ41536623-B5DF64C4-DC8D-4DB3-A09C-6FA6904CFABFQ42775546-75A1F1BF-8609-4212-9088-25AC8FABE3A5Q47235299-82D94293-A02F-4DD7-8659-E278EF2D7C7FQ47817708-33AB573C-A49A-4315-8A55-4D4158B30DCBQ48168643-7CE1A5EF-0664-4E6C-AEFA-CA9022B0F1B6Q51254914-7F658DA4-ED67-48B0-BE8B-21D10527EAF3Q51283525-F3FCC2AC-B621-4771-A2DD-854E7A07A70DQ51692429-4627EEB2-7463-4893-A4C3-609FFAB5E343Q73076403-EFB2C17A-7FD8-4007-84FB-32FD4BD3DB63Q73589468-FEAF263C-D6A8-4DED-A115-9DB8D308112FQ79785446-03613C56-EB9A-4274-B5E1-3DFD7E330F87Q79863270-BF24622A-8FDE-4C1F-A573-3862CAD262BF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Justin L Mott
@nl
Justin L Mott
@sl
Justin L. Mott
@en
Justin L. Mott
@es
type
label
Justin L Mott
@nl
Justin L Mott
@sl
Justin L. Mott
@en
Justin L. Mott
@es
prefLabel
Justin L Mott
@nl
Justin L Mott
@sl
Justin L. Mott
@en
Justin L. Mott
@es
P106
P1153
7005369780
P21
P31
P496
0000-0002-2927-6962